Phase I, single dose-ascending trial of E 52862 (5-500mg) in volunteers.
Phase of Trial: Phase I
Latest Information Update: 16 May 2016
At a glance
- Drugs E 52862 (Primary)
- Indications Acute pain; Neuropathic pain; Pain
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 16 May 2016 Pooled results of the phase I programme (see profiles 57703, 222641,57701) published in the Mundipharma media release.
- 30 May 2010 New trial record
- 30 May 2010 Results were reported at the 3rd International Congress on Neuropathic Pain.